Document Detail

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis.
MedLine Citation:
PMID:  21155084     Owner:  NLM     Status:  In-Process    
BACKGROUND: Psoriasis is a chronic inflammatory disease associated with comorbidities and decreased quality of life. This survey is aimed to better understand the impact of disease on Canadian patients, and to examine awareness and use of available treatment options.
METHODS: An online survey was conducted using a consumer panel. Eligible subjects reported diagnoses of psoriasis and moderate/severe/very severe plaque psoriasis within the past 5 years, and either: psoriasis covering ≥ 3% of body surface area; psoriasis on a sensitive area, or current use of systemic and/or phototherapy or light therapy for psoriasis.
RESULTS: A total of 514 panelists completed the survey; 65% reported current moderate/severe/very severe psoriasis. Awareness of available treatment options ranged from 98% for prescription topical agents to 75% for photo/light therapy, and < 50% for prescription oral (49%) or injectable (35%) medications. A total of 92% of respondents had been treated with and 61% were currently taking prescription topical agents. Photo/light therapy had been used by 38% and was currently used by 7% of respondents. Prescribed oral medication had been taken by 25% and was currently used by 8%. Few subjects had been treated with injectables in the past (10%) or currently (5%). Overall, 24% of respondents were very satisfied with their current treatment. A total of 63% of respondents taking injectables were very satisfied, compared with 38% of those taking prescribed oral medication and 21% of those receiving photo/light therapy.Conclusions Most respondents with moderate to severe psoriasis were unaware of all treatment options; systemic treatments were not commonly utilized. Treatment satisfaction rates were low, highlighting the need to ensure greater patient education on and use of available therapeutic options.
Yves Poulin; Kim A Papp; Norman R Wasel; Robin Andrew; Elisa Fraquelli; Geula Bernstein; Daphne Chan
Related Documents :
9553914 - Lipodystrophia centrifugalis abdominalis infantilis.
21346734 - Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective di...
7846284 - Brain choline in depression: in vivo detection of potential pharmacodynamic effects of ...
7932064 - Contagious depression: existence, specificity to depressed symptoms, and the role of re...
3796684 - Accurate prediction of the outcome of pediatric intensive care. a new quantitative method.
15673634 - Exploration of dsm-iv criteria in primary care patients with medically unexplained symp...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of dermatology     Volume:  49     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1368-75     Citation Subset:  IM    
Department of Medicine, Université Laval, Hôpital Hôtel-Dieu de Québec, Quebec, QC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literatur...
Next Document:  HLA-DR alleles associated with skin warts induced by human papillomavirus infection.